Roche Fined In Romania For Delaying Biosimilar Entry

Market Entry Delays Pushed Up Costs To National Insurer

Anti_Competitive_Practices
The Competition Council said Roche created barriers to market entry • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Legal & IP

More from Generics Bulletin